APA (7th ed.) Citation

Bárbara Lima, Miguel Henriques Abreu, Susana Sousa, Carla Bartosch, & Deolinda Pereira. (2022). Impressive and durable clinical responses obtained with dabrafenib and trametinib in low-grade serous ovarian cancer harbouring a BRAF V600E mutation. Elsevier.

Chicago Style (17th ed.) Citation

Bárbara Lima, Miguel Henriques Abreu, Susana Sousa, Carla Bartosch, and Deolinda Pereira. Impressive and Durable Clinical Responses Obtained with Dabrafenib and Trametinib in Low-grade Serous Ovarian Cancer Harbouring a BRAF V600E Mutation. Elsevier, 2022.

MLA (9th ed.) Citation

Bárbara Lima, et al. Impressive and Durable Clinical Responses Obtained with Dabrafenib and Trametinib in Low-grade Serous Ovarian Cancer Harbouring a BRAF V600E Mutation. Elsevier, 2022.